Diabetes

Women who develop gestational diabetes mellitus tend to have daughters who become obese later in childhood.

Draft guidance by the United States Preventive Services Task Force advocates screening patients with certain risk factors for impaired glucose tolerance to delay or prevent the onset of, and long-term damage due to, T2DM.

The rate of type 1 diabetes mellitus among non-Hispanic white youth increased significantly over an 8-year period.

Children infected with enterovirus have a 48% increased risk of developing type 1 diabetes.

Children infected with enterovirus have a 48% increased risk of developing type 1 diabetes.

Many cardiologists and pharmacists are concerned about clopidogrel, especially when it is prescribed for patients with diabetes.

Medication omission at discharge is the most common type of medication discrepancy.

Even a modest weight loss can improve overall health.

Even a modest weight loss can improve overall health.

The FDA has granted priority review to Roche's injectable ranibizumab (Lucentis) treatment for diabetic retinopathy.

A practical approach to daily life with the support of a pharmacist can make a difference.

Patients with diabetes may not know about OTC products formulated to meet their specific needs.

The FDA has approved the intravitreal implant, Iluvien 0.19 mg, as the first long-term treatment for diabetic macular edema.

The dexamethasone intravitreal implant, Ozurdex, is now indicated to treat all patients with diabetic macular edema.

Pharmacists who participate in community-based diabetes care teams play a pivotal role in reducing A1C levels among patients with poorly controlled diabetes.

A recent metaanalysis suggests that prediabetes increases the risk of developing certain cancers, particularly in tissues located near the gastrointestinal tract.

The FDA has cleared the Nova StatStrip Glucose Hospital Meter System to become the first blood glucose monitoring system for use in critically ill patients who have been hospitalized.

Combined with bolus insulin aspart (NovoLog), insulin degludec (Tresiba) improves long-term glycemic control in children and adolescents with type 1 diabetes.

The FDA today approved dulaglutide (Trulicity), a once-weekly injectable therapy indicated to improve blood sugar control in adults with type 2 diabetes.